Pengetahuan dan Sikap Pelaku Usaha di Kecamatan Mulyorejo terkait Vaksinasi COVID-19 Dosis Lanjutan (Booster)
Downloads
Vaksinasi COVID-19 dosis booster adalah salah satu kunci strategi untuk menekan angka peningkatan kasus COVID-19. Penolakan masyarakat Indonesia terhadap vaksin COVID-19 dosis booster akan menjadi penghalang yang krusial dalam mencapai herd immunity. Oleh karena itu, survei ini dilakukan untuk mengetahui bagaimana pengetahuan dan sikap pelaku usaha di Kecamatan Mulyorejo terhadap vaksin COVID 19 dosis booster. Cross sectional study dilaksanakan pada September 2022 dengan pengambilan data menggunakan kuesioner tervalidasi dalam bentuk google form dan kertas dengan jumlah pertanyaan sebanyak tiga belas untuk pengetahuan dan sepuluh untuk sikap. Survei dilakukan pada pelaku usaha di Kecamatan Mulyorejo yang memenuhi kriteria inklusi dan telah menandatangani informed consent. Hasil survei menunjukkan tingkat pengetahuan responden masuk pada kategori baik dengan jumlah persentase sebanyak 64,6% (n = 73) dan pada variabel sikap menunjukkan 54,9% (n = 62) responden mempunyai sikap positif dari total 113 responden. Survei ini menunjukkan sebagian besar pelaku usaha di daerah Mulyorejo memiliki pengetahuan yang baik dan sikap yang positif terkait vaksinasi dosis lanjutan (booster). Namun, edukasi dan promosi kesehatan perlu dilakukan untuk meningkatkan pengetahuan dan sikap pelaku usaha lain yang masih belum optimal.
Aklil, M. B. and Temesgan, W. Z. (2022) ‘Knowledge
and attitude towards COVID-19 vaccination and associated factors among college students in Northwest Ethiopia,2021.', Health Services Research and Managerial Epidemiology, 9, pp. 1-11. doi: 10.1177/23333928221098903.
Bintang, A. (2022) ‘Kota Surabaya dalam Angka 2022',
Badan Pusat Statistik Kota Surabaya. Available at: http://bappeda.jatimprov.go.id/bappeda/wp-content/uploads/potensi-kab-kota-2013/kota-surabaya-2013.pdf.
BPS Kota Surabaya. (2022) ‘Kecamatan Mulyorejo dalam Angka 2022'., Badan Pusat Statistik Kota Surabaya.
Centers for Disease Control and Prevention (CDC). (2021) 'Basics of COVID-19 viewed 4 November 2022.' https://www.cdc.gov/coronavirus/2019-ncov/your-health/about-COVID-19/basics-COVID-19.html.
Centers for Disease Control and Prevention. (2022) ‘Understanding How COVID-19 Vaccines Work'. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html
Centers for Disease Control and Prevention. (2022) ‘Stay Up to Date with COVID-19 Vaccines Including Boosters.', https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html.
Dinina, F., Setiawan, D., Kristianawati, S., Pratiwi, V.D. Ristanti, A.D., Nabila, F., Rahma, A., Fajar, D., Softyana, V., WIndasari, D., Bachmid, Q., Nugraheni, G. (2021) ‘Profil Pengetahuan dan Tingkat Kepatuhan terhadap Protokol Kesehatan COVID-19 oleh Masyarakat di Area Pedesaan.', Jurnal Farmasi Komunitas, 9(1), pp. 1-9. doi: 10.20473/jfk.v9i1.24087.
Frederiksen, L., Zhang, Y., Foged, C. & Thakur, A. (2020) ‘The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies'. Immunology, Issue Frontiers Media, 11(1817), pp. 1-26. doi: 10.3389/fimmu.2020.01817
Harahap, A. R. N. (2022) ‘Efektivitas Vaksin COVID-19 dalam Kinerjanya untuk Memodulasi Imunitas Tubuh Melawan Infeksi SARS-COV-2. Ilmu Keperawatan dan Kesehatan,3(1), pp. 1-10. doi: 10.37287/ijnhs.v3i1.906
Kemenkes RI. (2020) ‘Surat Edaran
HK.01.07/menkes/382/2020 tentang protokol kesehatan bagi masyarakat di tempat dan fasilitas umum dalam rangka pencegahan dan pengendalian Corona virus disease 2019 (COVID-19).', Jakarta: Kemenkes RI (Direktorat Jenderal Pencegahan dan Pengendalian Penyakit).
Kemenkes RI. (2021) ‘Surat Edaran HK.02.01/I/2524/2021tentang vaksinasi COVID-19 bagi penyintas'. Jakarta: Kemenkes RI (Direktorat Jenderal Pencegahan dan Pengendalian Penyakit).
Kemenkes RI. (2022). Vaksin Dashboard viewed 28
Agustus 2022. https://vaksin.kemkes.go.id/#/detail_data.
Kemenkes RI. (2022) ‘Surat Edaran Nomor
SR.02.06/II/1188/2022 tentang Penambahan Regimen Vaksinasi COVID-19 Dosis Lanjutan'. Jakarta: Kemenkes RI (Direktorat Jenderal Pencegahan dan Pengendalian Penyakit).
Kemenkes RI. (2022) ‘Surat Edaran HK.02.02/II/252/2022 tentang Vaksinasi COVID-19 Dosis Lanjutan'. Jakarta: Kemenkes RI (Direktorat Jenderal Pencegahan dan Pengendalian Penyakit).
Kurniawan, D. and Sutan, A. J. (2021) ‘Penggunaan Sosial Media Dalam Menyebarkan Program Vaksinasi COVID-19 Di Indonesia', Kebijakan Publik, 12(1), pp. 27–34. doi: 10.31258/jkp.v12i1.7930.
Kwok, K. O., Lai, F., Wei, W., Wong, S. Y., and Tang, J. WT. (2020) ‘Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries'. Journal Of Infection, 80(6), pp. 32-33. doi: 10.1016/j.jinf.2020.03.027.
Lan F., Suharlim, C., Kales, S. N., and Yang, . (2021) ‘Association between SARS-CoV-2 infection, exposure risk and mental health among a cohort of essential retail workers in the USA. Occupational and Environmental Medicine'; 78(4), pp. 237-243. doi: 10.1136/oemed-2020-106774.
Meo, S. A., Bukhari, I.A., Akram, J., Meo, A.S., and Klonoff, D. C. (2021) ‘COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Medical and Pharmacological Sciences', Issue Europe Review Medical Pharmacological Sciences, 25(3), pp. 1663-1669. doi: 10.26355/eurrev_202102_24877
Occupational Safety and Health Administration. Worker
Exposure Risk to COVID-19 viewed 5 September 2022. https://www.osha.gov/sites/default/files/publications/OSHA3993.pdf.
Ong, S. Q., Pauzi, M., and Gan, K. H. (2022) ‘Text Mining and Determinants of Sentiments towards the COVID-19 Vaccine Booster of Twitter Users in Malaysia'. Healthcare (Basel, Switzerland), 10(6), pp. 994. doi: 10.3390/healthcare10060994.
Plans, P., Torner, N., Godoy, P., and Jane, M. (2013) ‘Lack of herd immunity against measles in individuals aged <35 years could explain re-emergence of measles in Catalonia (Spain)'. International Journal of Infectious Diseases, 18(1), pp. 81-83. doi: 10.1016/j.ijid.2013.09.015.
Samanta, S., Banerjee, J., Kar, S.S., Ali, K. M., Giri, B., Pal, A., Dash, S. K. (2022) ‘Awareness, knowledge and acceptance of COVID-19 vaccine among the people of West Bengal, India: A web-based survey', Vacunas, 23(5), pp. S46–S55. doi: 10.1016/j.vacun.2022.01.002.
Santiago, J. M. and Santos, A. R. (2022) ‘Knowledge and attitudes towards COVID-19 vaccines among university students, faculty members and staffs', International Journal of Public Health Science, 11(2), pp. 654–662. doi: 10.11591/ijphs.v11i2.21169.
Schober, P., Boer, C., and Schwarte, L. A. (2018) 'Correlation Coefficients: Appropiate Use and Interpretation'. Medical Research, 126(5), pp. 1763-1768. doi: 10.1213/ANE.0000000000002864
Surat Edaran Nomor HK.02.02/I/2529/2021. Tentang vaksinasi COVID-19 Bagi Penyintas. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. 29 september 2021
WHO. (2021) ‘Interim Statement On Booster Doses For COVID-19 Vaccination' viewed 28 Agustus 2022. https://www.who.int/news/item/04-10-2021-interim-statement-on-booster-doses-for-COVID-19-vaccination.
Copyright (c) 2023 Jurnal Farmasi Komunitas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
In order to be accepted and published by JFK, author(s) submitting the article manuscript should complete all the review stages. By submitting the manuscript, the author(s) agreed to these following terms:
1. Copyright of the article is transferred to the journal (JFK), by the knowledge of the author, whilst the moral right of the publication belongs to the author. The intended copyright includes the rights to publish articles in various forms (including reprints). JFK maintain the publishing rights to the published articles.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
The Copyright Transfer Agreement Form can be downloaded ON THIS FORM.
Jurnal Farmasi Komunitas (JFK) by Unair is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
